3 Australian Growth Stocks With Revenue Growth Up To 37%

Sep 21, 2026
3-australian-growth-stocks-with-revenue-growth-up-to-37%

Higher long term interest rates in the US are reshaping how money is priced around the world, and that includes Australian growth stories. Expensive debt can make slower businesses feel the strain, while fast growing companies with high insider ownership may still push ahead using retained cash and aligned management. This article looks at three such Australian stocks that fit that profile and explains what makes each one worth a closer look.

The stocks covered next are only a small sample, and the full screen surfaced 110 more fast growing, high-insider-ownership companies with equally compelling narratives that are not included here. To go straight to the full Fast Growing Stocks With High Insider Ownership results, analyze the list and identify your own highest conviction ideas directly inside the Fast Growing Stocks With High Insider Ownership screener.

Liontown (ASX:LTR)

Overview: Liontown is a Perth based miner focused on developing the Kathleen Valley hard rock lithium project, alongside earlier stage gold and nickel exploration.

Operations: Liontown reported A$639 million in revenue from exploration and development of minerals, all generated within Australia.

Market Cap: A$3.2b

Liontown gives this screener a clear lithium production story, with Kathleen Valley aimed squarely at supplying material for the EV and battery chain.

“The company has initiated trials with higher contamination ore, achieving higher lithium recovery rates while maintaining strong recovery even with lower-grade material. This could improve net margins by optimizing processing costs over time.”

What happens to Liontown’s earnings profile from here rests heavily on how one unseen pressure on future unit costs plays out.

If that cost pressure matters to you, read the full narrative for Liontown to see how Liontown’s capital choices and pricing power could reshape the story.

ASX:LTR Earnings & Revenue History as at Sep 2026
ASX:LTR Earnings & Revenue History as at Sep 2026

PDI Gold (ASX:PDI)

Overview: PDI Gold is a West Africa focused gold explorer and producer built around the Kiniéro Gold project in Guinea, which anchors its growth potential.

Market Cap: A$4.9b

PDI Gold fits this high growth, high insider alignment theme because Kiniéro underpins a multi year expansion plan that management is actively reshaping the whole business around.

“Free cash flow from Kiniero is already being used to fund Bankan execution planning and long lead work, which reduces reliance on external capital and can support future returns on capital, net margins and earnings if development progresses as outlined.”

What happens if one assumption behind that reinvestment loop shifts will go a long way toward deciding how durable those returns look.

If that loop breaks, or accelerates, the full narrative for PDI Gold explains how PDI Gold’s capital cycle, risk profile and upside case could shift from here.

ASX:PDI Earnings & Revenue History as at Sep 2026
ASX:PDI Earnings & Revenue History as at Sep 2026

Mesoblast (ASX:MSB)

Overview: Mesoblast develops regenerative cell therapies based on mesenchymal lineage cells, with late-stage candidates targeting severe inflammatory and cardiovascular conditions.

Operations: Mesoblast reports US$120 million in revenue from development and commercialization of its allogeneic cellular medicines platform.

Market Cap: A$2.7b

Mesoblast fits the Fast Growing Stocks With High Insider Ownership theme through a late-stage cell therapy pipeline, where commercial traction and management conviction both tie directly to future growth potential.

“The first and only FDA approved mesenchymal stromal cell product in the U.S., Ryoncil, together with over 1,100 patents and established commercial scale manufacturing, positions Mesoblast to benefit if cell therapies gain wider medical adoption.”

What happens when one key assumption about how quickly physicians and payers embrace these therapies shifts will matter a great deal.

That adoption curve is the real hinge for Mesoblast, and the full narrative for Mesoblast shows how regulatory momentum, capital needs and upside could accelerate or stall.

ASX:MSB Earnings & Revenue History as at Sep 2026
ASX:MSB Earnings & Revenue History as at Sep 2026

Seeking Alternatives Before The Crowd?

Fresh ideas move first. Breakout themes, early momentum and under the radar stories get caught quickly and pricing power can drop fast. Scan these curated lists and consider acting early.

  • Target income that keeps working while markets move by reviewing the 4 dividend fortresses curated for durability and yield focus.
  • Explore secular demand for critical metals by scanning the 17 top copper producer stocks that highlights producers positioned for long term supply pressure.
  • Track where robotics demand could build next by running through the 96 robotics and automation stocks featuring companies tied to automation spending.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We’ve created the ultimate portfolio companion for stock investors, and it’s free.

• Connect an unlimited number of Portfolios and see your total in one currency

• Be alerted to new Warning Signs or Risks via email or mobile

• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Leave a comment